[ASAP] Orally Active Forms of DMT, 5 ‑MeO-DMT, and Long-Acting MDMA for the Treatment of Neuropsychiatric Disorders

ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.3c00077

Source: ACS Medicinal Chemistry Letters - March 16, 2023 Category: Chemistry Authors: Robert B. Kargbo Source Type: research